Phillip J. Buckhaults

Affiliations: 
Drug Discovery & Biomedical Sciences University of South Carolina, Columbia, SC 
Google:
"Phillip Buckhaults"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Khalili S, Mohseninia A, Liu C, et al. (2025) Comprehensive genomic dependency landscape of a human colon cancer organoid. Communications Biology. 8: 436
Massey JC, Magagnoli J, Sutton SS, et al. (2024) Collateral damage of NUDT15 deficiency in cancer provides a cancer pharmacogenetic therapeutic window with thiopurines. Biorxiv : the Preprint Server For Biology
Vu T, Datta A, Banister C, et al. (2021) STRAP is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis through a Feed-Forward Mechanism. Gastroenterology
Hofseth LJ, Hebert JR, Chanda A, et al. (2020) Publisher Correction: Early-onset colorectal cancer: initial clues and current views. Nature Reviews. Gastroenterology & Hepatology
Saatci O, Kaymak A, Raza U, et al. (2020) Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. Nature Communications. 11: 2416
Kundu A, Nam H, Shelar S, et al. (2020) PRDM16 suppresses HIF-targeted gene expression in kidney cancer. The Journal of Experimental Medicine. 217
Hofseth LJ, Hebert JR, Chanda A, et al. (2020) Early-onset colorectal cancer: initial clues and current views. Nature Reviews. Gastroenterology & Hepatology
Makena MR, Dang D, Mekile A, et al. (2020) Abstract 5276: Secretory pathway calcium ATPase 2 (SPCA2) promotes cell survival and chemoresistance in receptor positive breast cancer cells Cancer Research. 80: 5276-5276
Dwyer AJ, Murphy CC, Boland CR, et al. (2019) A summary of the Fight Colorectal Cancer working meeting: exploring risk factors and etiology of sporadic early-age onset colorectal cancer. Gastroenterology
Liu C, Banister CE, Buckhaults PJ. (2019) Spindle assembly checkpoint inhibition can resensitize p53-null stem cells to cancer chemotherapy. Cancer Research
See more...